Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinics (Sao Paulo, Brazil)|April 24, 2012
Castration-resistant prostate cancer: systemic therapy in 2012Fernando C Maluf, Oren Smaletz, Daniel Herchenhorn
Gynecologic Oncology Reports|December 6, 2017
Ovarian yolk sac tumor coexisting with epithelial ovarian cancer: An aggressive rare entityPatrícia Taranto, Filomena M Carvalho, Sergio Roithmann, et al.
JCO Global Oncology|June 26, 2025
Survival According to Source of Treatment Funding in Bladder Cancer: Analysis of a Large Public Database From São Paulo, BrazilFernando C Maluf, Cintia S K S de Oliveira, Patrícia K Ziegelmann
Annals of Diagnostic Pathology|March 16, 2010
A new morphological variant of uterine PEComas with sex-cord-like pattern and WT1 expression: more doubts about the existence of uterine PEComasFilomena M Carvalho, Jesus Paula Carvalho, Fernando C Maluf, et al.
Cancer|July 13, 2002
High-grade gliomas in patients with prior systemic malignanciesFernando C Maluf, Lisa M DeAngelis, Jeffrey J Raizer, et al.
JCO Global Oncology|February 6, 2025
Impact of Funding Source on Long-Term Outcomes in Prostate Cancer: Analysis of a Large Public Database From Sao Paulo, BrazilFernando C Maluf, Cintia S K S de Oliveira, Patrícia K Ziegelmann
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 26, 2018
Worst outcomes according to RAS mutation variants: an analysis in patients with metastatic colorectal adenocarcinomaPedro L S Usón, Diogo D G Bugano, Fernando Moura, et al.
Journal of Gastrointestinal Cancer|September 20, 2017
Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced Pancreatic CancerPedro L S Usón Junior, Donato Callegaro-Filho, Diogo D G Bugano, et al.
Head & Neck|January 26, 2007
Necrotizing fasciitis as a late complication of multimodal treatment for locally advanced head and neck cancer: a case reportFernando C Maluf, William N William, Otelo Rigato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urotheliumMatthew I Milowsky, David M Nanus, Fernando C Maluf, et al.
Pageof 2